scholarly article | Q13442814 |
P50 | author | Jung Ho Kim | Q89340476 |
Kwang An Kwon | Q89340492 | ||
Dong Kyun Park | Q89340494 | ||
Sungjin Park | Q89518808 | ||
Seungyoon Nam | Q89518809 | ||
P2093 | author name string | Jungsuk An | |
Sanghoon Han | |||
Woon Kee Lee | |||
Jun-Young Yang | |||
Yoon Jae Kim | |||
Kyoung Oh Kim | |||
Jun-Won Chung | |||
P2860 | cites work | HER2 Status in Premalignant, Early, and Advanced Neoplastic Lesions of the Stomach | Q26780318 |
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial | Q27851578 | ||
Comprehensive molecular characterization of gastric adenocarcinoma | Q28244985 | ||
Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal | Q28288215 | ||
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2014 | Q33584023 | ||
Biochemical and clinical implications of the ErbB/HER signaling network of growth factor receptors | Q33767107 | ||
Effects of screening on gastric cancer management: comparative analysis of the results in 2006 and in 2011. | Q33927580 | ||
Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers | Q34620983 | ||
Biopathologic features and clinical significance of micrometatasis in the lymph node of early gastric cancer | Q34932726 | ||
Increased signalling of EGFR and IGF1R, and deregulation of PTEN/PI3K/Akt pathway are related with trastuzumab resistance in HER2 breast carcinomas. | Q35889941 | ||
Assessment of a HER2 scoring system for gastric cancer: results from a validation study | Q37142266 | ||
HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target | Q37149210 | ||
Predicting lymph node status in early gastric cancer | Q37282324 | ||
Effectiveness of the Korean National Cancer Screening Program in Reducing Gastric Cancer Mortality | Q38986387 | ||
Integrated genomic characterization of oesophageal carcinoma | Q39041152 | ||
Discordance in HER2 Status in Gastro-esophageal Adenocarcinomas: A Systematic Review and Meta-analysis | Q39363485 | ||
Japanese gastric cancer treatment guidelines 2014 (ver. 4). | Q39656427 | ||
Prognostic significance of performing universal HER2 testing in cases of advanced gastric cancer. | Q40592991 | ||
Decreased death from gastric cancer by endoscopic screening: association with a population-based cancer registry | Q43525350 | ||
Diagnostic, Predictive, Prognostic, and Therapeutic Molecular Biomarkers in Third Millennium: A Breakthrough in Gastric Cancer. | Q48379063 | ||
HER2 testing of gastro-oesophageal adenocarcinoma: a commentary and guidance document from the Association of Clinical Pathologists Molecular Pathology and Diagnostics Committee | Q50036642 | ||
The incidence of lymph node metastasis in early gastric cancer according to the expanded criteria in comparison with the absolute criteria of the Japanese Gastric Cancer Association: a systematic review of the literature and meta-analysis. | Q51805852 | ||
Clinicopathological and prognostic significance of HER2 overexpression in gastric cancer: a meta-analysis of the literature. | Q53134672 | ||
Effect of repeated endoscopic screening on the incidence and treatment of gastric cancer in health screenees. | Q53511404 | ||
HER2/neu over-expression predicts poor outcome in early gastric cancer without lymph node metastasis. | Q54325866 | ||
Long-term outcomes of endoscopic submucosal dissection for early gastric cancer: a multicenter collaborative study | Q56763795 | ||
Early HER2 dysregulation in gastric and oesophageal carcinogenesis | Q58003579 | ||
Number of lymph node metastases and its prognostic significance in early gastric cancer: a multicenter Italian study | Q80135910 | ||
Japanese classification of gastric carcinoma: 3rd English edition | Q84106763 | ||
Is endoscopic resection an alternative to surgery for early low-risk submucosal gastric cancers: analysis of a large surgical database | Q85709378 | ||
HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline Summary From the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical Oncology | Q88889087 | ||
Sex-specific differences in risk factors of lymph node metastasis in patients with early gastric cancer | Q90797232 | ||
Pretreatment diagnosis factors associated with overtreatment with surgery in patients with differentiated-type early gastric cancer | Q90950790 | ||
Automated detection of the HER2 gene amplification status in Fluorescence in situ hybridization images for the diagnostics of cancer tissues | Q92502340 | ||
P433 | issue | 1 | |
P921 | main subject | biomarker | Q864574 |
lymph node metastasis | Q2774221 | ||
P304 | page(s) | 5270 | |
P577 | publication date | 2020-03-24 | |
P1433 | published in | Scientific Reports | Q2261792 |
P1476 | title | HER2 as a potential biomarker of lymph node metastasis in undifferentiated early gastric cancer | |
P478 | volume | 10 |
Search more.